argus

Dr. Lal Pathlabs Limited

NSE: LALPATHLABINE600L0102431,950 Cr

Timeline

Time (IST)TypeMEventSrc
30 Apr, 03:35 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Mr Rajit Mehta as Non- Executive Independent Director of the company w.e.f. July 27, 2026.nse
30 Apr, 03:35 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Mr Arvind Lal as Executive Director of the company w.e.f. April 01, 2027.nse
30 Apr, 03:34 pmDr. Lal PathLabs Ltd - 539524 - Re-Appointment Of M/S Ernst & Young LLP (EY) As Internal Auditors And M/S A.G. Agarwal & Associates As Cost Auditorsbse
30 Apr, 03:32 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
30 Apr, 03:31 pmDr. Lal PathLabs Ltd - 539524 - The Record Date For The Purpose Of Payment Of Final Dividend Shall Be June 26, 2026bse
30 Apr, 03:28 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
30 Apr, 03:28 pmDr. Lal Path Labs Ltd. has informed the Exchange that Record date for the purpose of Dividend is 26-Jun-2026.nse
30 Apr, 03:26 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on April 30, 2026.nse
30 Apr, 03:24 pmDr. Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on April 30, 2026, recommended Final Dividend of Rs. 4 per equity share.nse
30 Apr, 03:23 pmDr. Lal PathLabs Ltd - 539524 - Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026.bse
30 Apr, 03:21 pmDr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
23 Apr, 06:16 pmDr. Lal PathLabs Ltd - 539524 - Corporate Action-Board to consider Dividendbse
23 Apr, 06:13 pmDr. Lal PathLabs Ltd - 539524 - Update on board meetingbse
27 Mar, 12:49 pmDr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for Notice Of Board Meetingbse
25 Mar, 05:21 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
25 Mar, 05:19 pmDr. Lal Path Labs Ltd. has informed the Exchange about Credit Rating- Revision (Upgraded from CARE AA; Stable to CARE AA+; Stable)nse
10 Mar, 03:35 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding 'Update on Voluntary Liquidation of Suburban Diagnostics (India) Private Limited (a Wholly Owned Subsidiary of the Company) Receipt of NCLT Order'.nse
03 Feb, 04:23 pmDr. Lal Path Labs Ltd. has informed the Exchange about Transcriptnse
03 Feb, 04:19 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
30 Jan, 06:38 pmDr. Lal Path Labs Ltd. has informed the Exchange about Link of Recordingnse
30 Jan, 06:36 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jan, 01:41 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025".nse
30 Jan, 01:40 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
30 Jan, 01:39 pmDr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentationnse
30 Jan, 01:38 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Jan, 01:27 pmDr. Lal Path Labs Ltd. has informed the Exchange that Record date for the purpose of Dividend is 05-Feb-2026.nse
30 Jan, 01:25 pmDr. Lal PathLabs Ltd - 539524 - Fixes Record Date For 3Rd Interim Dividend FY 2025-26bse
30 Jan, 01:23 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on January 30, 2026.nse
30 Jan, 01:22 pmDr. Lal PathLabs Ltd - 539524 - Corporate Action-Board approves Dividendbse
30 Jan, 01:20 pmDr. Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on January 30, 2026, declared Interim Dividend of Rs. 3.5 per equity share.nse
30 Jan, 01:18 pmDr. Lal PathLabs Ltd - 539524 - Financial Results For The Quarter And Nine Months Ended December 31, 2025bse
30 Jan, 01:17 pmDr. Lal PathLabs Ltd - 539524 - Financial Results For The Quarter And Nine Months Ended December 31, 2025bse
30 Jan, 01:17 pmDr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
23 Jan, 12:10 pmDr. Lal PathLabs Ltd - 539524 - Update on board meetingbse
23 Jan, 12:07 pmDr. Lal PathLabs Ltd - 539524 - Corporate Action-Board to consider Dividendbse
06 Jan, 09:05 amDr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 06, 2026, titled "Dr. Lal PathLabs launches SOVAAKA a next-generation wellness centre blending science, technology, and personalized care".nse
06 Jan, 09:05 amDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
29 Dec, 12:45 pmDr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for Notice Of Board Meetingbse
22 Dec, 09:20 amDr. Lal Path Labs Ltd. has informed the Exchange regarding allotment of 83775510 securities by the Board pursuant to Bonus Issue through circular resolution on December 22, 2025nse
22 Dec, 09:11 amDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Allotmentbse
15 Dec, 06:28 pmDr. Lal Path Labs Ltd. has informed the Exchange about amended trustdeed w.r.t changes consequent upon introduction of Dr. Lal PathLabs EmployeeRestricted Stock Unit Plan 2025 (RSU 2025).nse
15 Dec, 06:22 pmDr. Lal PathLabs Ltd - 539524 - Amended Trust Deed (ESOP)bse
12 Dec, 04:28 pmDr. Lal Path Labs Ltd. has informed the Exchange that Record date for the purpose of Bonus is 19-Dec-2025.nse
12 Dec, 04:26 pmDr. Lal PathLabs Ltd - 539524 - Intimation Of Record Date For The Purpose Of Issuing Bonus Equity Sharesbse
09 Dec, 03:47 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding 'Updates'.nse
08 Dec, 03:37 pmDr. Lal Path Labs Ltd. has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
08 Dec, 03:36 pmDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
26 Nov, 10:06 amDr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
26 Nov, 10:05 amDr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 26, 2025, titled "Dr. Lal PathLabs Strengthens Autoimmune Diagnosis with Indias First Comprehensive Complement Lab".nse
06 Nov, 05:42 pmDr. Lal Path Labs Ltd. has informed the Exchange about Transcriptnse